FAPI PET/CT
FAPI PET/CT is a medical procedure with 8 clinical trials. Currently 5 active trials ongoing.
Success Metrics
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
0.0%
0 of 0 finished
0.0%
0 ended early
5
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Role of the Imaging FAPI PET/CT in Exploring the Microenvironment of Colorectal Cancer Liver Metastases
Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis
Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors
The Role of FAPI PET-CT in Diagnosing Endometriosis
The Diagnostic Value of FAPI PET/CT in Staging of Newly Diagnosed Prostate Cancer
Clinical Trials (8)
The Role of the Imaging FAPI PET/CT in Exploring the Microenvironment of Colorectal Cancer Liver Metastases
Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis
Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors
The Role of FAPI PET-CT in Diagnosing Endometriosis
The Diagnostic Value of FAPI PET/CT in Staging of Newly Diagnosed Prostate Cancer
Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors
Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases
FAPI PET/CT for Lymph Node Staging in Colorectal Carcinoma
All 8 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 8